Plasmid-mediated quinolone resistance in different diarrheagenic Escherichia coli pathotypes 4 responsible for complicated, non-complicated, and travelers' diarrhea cases 5 6
industrialized countries (2). EAEC, ETEC, EPEC, and EIEC are generally considered major 23 causes of travelers' diarrhea in adults from developed countries and the leading causes of 24 infant diarrhea in developing ones (2). 25 2
The first-choice agents for treating DEC infections are quinolones, together with 26 rifaximin and azithromycin (3), although the use of quinolones concretely in STEC 27 complicated infections remains controversial, as they have been postulated to increase the 28 risk of development of HUS (4). However, plasmid-mediated quinolone resistance genes 29 (qnr) encoding small pentapeptide-repeat proteins that protect type II DNA topoisomerases 30 from quinolones have been described, including five qnr families [qnrA1-7, qnrB1-74, qnrC, 31 qnrD1-2 and qnrS1-9 (http://www.lahey.org/qnrstudies)]. qnr genes by themselves are able 32 to confer only a low-level quinolone resistance, but they have been proposed to promote the 33 emergence of chromosomal mutations leading to resistance levels of clinical significance (5). 34 Although the occurrence of qnr genes has been widely documented in extraintestinal E. coli 35 (6), studies concerning qnr occurrence in DEC are scarce and, as far as we know, it has not 36
been reported yet in clinical DEC strains other than EAEC (7, 8). 37 A routine screening for susceptibility to 13 different antimicrobials was carried out with 38 54 STEC, 16 aEPEC, 9 EAEC, 6 ETEC, and 2 EIEC strains (87 strains in total) isolated from 39 Etests. Additionally, to evaluate the possible association between qnr genes and the 48 production of ESBLs, the ESBL phenotype was detected by the double synergy test. PCR and 49 DNA sequencing were used to confirm the presence of qnr genes and identify the qnrA, 50 3 qnrB, qnrC, qnrD, and qnrS alleles, as well as β-lactamase (bla) alleles, as previously 51 described (9). Conjugation experiments were used to determine the transfer of resistance 52 using a rifampicin-resistant E. coli as recipient and all qnr-harbouring strains as donors and 53 rifampicin (50 μg/ml) and ampicillin/streptomycin (100 μg/ml) to select transconjugants (9). 54
The presence of plasmids and plasmid sizes were assessed by S1-PFGE and plasmid 55 extraction with the QIAprep Spin Miniprep Kit (Qiagen) from every parental and 56 transconjugant strain, and their incompatibility groups were established by PCR-based 57 replicon typing (10). The location of qnr and bla genes was determined by Southern blot 58 hybridization using PCR-generated digoxigenin-labelled probes (9). 59
Overall, four DEC strains out of 87 (4.6%) exhibited a decreased ciprofloxacin 60 susceptibility (MIC 0.38-1.5 μg/ml), with three of them being still susceptible to nalidixic 61 acid (MIC 6-16 μg/ml) ( Table 1) . As these values have been previously proposed to identify 62 qnr-positive strains (5, 9), the presence of qnr genes was confirmed on the four strains. 63
Concretely, qnrB19 was identified in an EAEC strain isolated from an adult with diarrhea 64 travelling from Mexico and also in a STEC O157:H7 strain isolated from a 7-year-old boy 65 suffering from HUS after diarrhea (Table 1) . Likewise, qnrS1 was detected in an aEPEC 66 strain isolated from a 1-year-old boy with non-complicated diarrhea and also in an EIEC 67 strain isolated from an adult with diarrhea travelling from South-East Asia (Table 1) . This 68 latter EIEC strain showed a resistance phenotype indicating ESBL production and harbored 69 the ESBL gene bla CTX-M-15 (Table 1) . Conjugation experiments were positive for the EAEC, 70 aEPEC, and EIEC strains, and therefore three transconjugants were obtained. Plasmid 71 analysis showed that qnrB19 was transferred on a ColE Tp plasmid of ≈3 kb in the EAEC 72 strain (Table 1 ). In the aEPEC strain, qnrS1 was transferred on a non-typeable plasmid of ≈48 73 kb, and co-transfer of bla TEM1 gene was observed (Table 1 ). In the ESBL-producing EIEC 74 strain, qnrS1 was transferred with bla CTX-M-15 and bla TEM1 on an IncK plasmid of ≈97 kb 75 4 (Table 1) . Finally, in the STEC O157:H7 strain, qnrB19 was harboured on a non-conjugative 76 ColE Tp plasmid of ≈3.5 kb (Table 1) . 77
To our knowledge this is the first report of the occurrence of qnr genes in STEC, aEPEC, 78 and EIEC clinical strains. Our study also confirms the occurrence of qnr genes in EAEC 79 strains reported by Riveros et al. (7) and Kim et al. (8) , which might have contributed to the 80 increasing trend of fluoroquinolone resistance recently observed in this E. coli pathotype 81 worldwide (7, 11). As for the plasmids, although qnrB19 has previously been found in ColE-82 like plasmids (7, 12), qnrS1 has rarely been found in incK plasmids, mainly involved in the 83 spreading of bla CTX-M-14 (13). Many surveys have shown qnr-positive Enterobacteriaceae 84 simultaneously expressing plasmid-encoded β-lactamases, because genes encoding ESBLs 85
and AmpC β-lactamases are often found on the same plasmid than qnr genes (5, 9). 86
Nevertheless, although the presence of bla CTX-M-15 in incK plasmids from E. coli has been 87 recently reported (14) and qnrS1 has been recently found linked to the AmpC β-lactamase 88 bla CMY-2 in multiresistance incK plasmids from E. coli (15), to our knowledge no IncK 89 plasmid simultaneously harboring qnrS1 and bla CTX-M-15 has been reported yet. 90
Although the clinical implications of our findings are still unknown, it may be speculated 91 that qnr genes might play a significant role in therapeutic failures in DEC infections and so 92 this is very important to take into consideration when working with diarrhea cases and their 93 treatment. In addition, epidemiologic surveillance and correct use of antimicrobial agents are 94 needed to limit the spread of plasmid-mediated quinolone resistances. 95 
